Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SARAU HM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 57 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sarau, HM; Widdowson, KL; Palovich, MR; White, JR; Underwood, DC; Griswold, DE
      Interleukin-8 receptor (CXCR2) antagonists

      NEW DRUGS FOR ASTHMA, ALLERGY AND COPD
    2. Dhanak, D; Christmann, LT; Darcy, MG; Jurewicz, AJ; Keenan, RM; Lee, J; Sarau, HM; Widdowson, KL; White, JR
      Discovery of potent and selective phenylalanine derived CCR3 antagonists. Part 1

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    3. Dhanak, D; Christmann, LT; Darcy, MG; Keenan, RM; Knight, SD; Lee, J; Ridgers, LH; Sarau, HM; Shah, DH; White, JR; Zhang, LL
      Discovery of potent and selective phenylalanine derived CCR3 receptor antagonists. Part 2

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    4. Zhu, Y; Michalovich, D; Wu, HL; Tan, KB; Dytko, GM; Mannan, IJ; Boyce, R; Alston, J; Tierney, LA; Li, XT; Herrity, NC; Vawter, L; Sarau, HM; Ames, RS; Davenport, BM; Hieble, JP; Wilson, S; Bergsma, DJ; Fitzgerald, LR
      Cloning, expression, and pharmacological characterization of a novel humanhistamine receptor

      MOLECULAR PHARMACOLOGY
    5. Robert, P; Tsui, P; Laville, MP; Livi, GP; Sarau, HM; Bril, A; Berrebi-Bertrand, I
      EDG1 receptor stimulation leads to cardiac hypertrophy in rat neonatal myocytes

      JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
    6. Blaney, FE; Raveglia, LF; Artico, M; Cavagnera, S; Dartois, C; Farina, C; Grugni, M; Gagliardi, S; Luttmann, MA; Martinelli, M; Nadler, GMMG; Parini, C; Petrillo, P; Sarau, HM; Scheideler, MA; Hay, DWP; Giardina, GAM
      Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity andselectivity in quinoline tachykinin receptor antagonists

      JOURNAL OF MEDICINAL CHEMISTRY
    7. Ames, RS; Lee, D; Foley, JJ; Jurewicz, AJ; Tornetta, MA; Bautsch, W; Settmacher, B; Klos, A; Erhard, KF; Cousins, RD; Sulpizio, AC; Hieble, JP; McCafferty, G; Ward, KW; Adams, JL; Bondinell, WE; Underwood, DC; Osborn, RR; Badger, AM; Sarau, HM
      Identification of a selective nonpeptide antagonist of the anaphylatoxin C3a receptor that demonstrates antiinflammatory activity in animal models

      JOURNAL OF IMMUNOLOGY
    8. Muir, AI; Chamberlain, L; Elshourbagy, NA; Michalovich, D; Moore, DJ; Calamari, A; Szekeres, PG; Sarau, HM; Chambers, JK; Murdock, P; Steplewski, K; Shabon, U; Miller, JE; Middleton, SE; Darker, JG; Larminie, CGC; Wilson, S; Bergsma, DJ; Emson, P; Faull, R; Philpott, KL; Harrison, DC
      AXOR12, a novel human G protein-coupled receptor, activated by the peptideKiSS-1

      JOURNAL OF BIOLOGICAL CHEMISTRY
    9. Sarau, HM; Feild, JA; Ames, RS; Foley, JJ; Nuthulaganti, P; Schmidt, DB; Buckley, PT; Elshourbagy, NA; Brawner, ME; Luttmann, MA; Giardina, GAM; Hay, DWP
      Molecular and pharmacological characterization of the murine tachykinin NK3 receptor

      EUROPEAN JOURNAL OF PHARMACOLOGY
    10. Johanson, RA; Sarau, HM; Foley, JJ; Slemmon, JR
      Calmodulin-binding peptide PEP-19 modulates activation of calmodulin kinase II in situ

      JOURNAL OF NEUROSCIENCE
    11. Sarau, HM; Mooney, JL; Schmidt, DB; Foley, JJ; Buckley, PT; Giardina, GAM; Wang, DY; Lee, JA; Hay, DWP
      Evidence that the proposed novel human "neurokinin-4" receptor is pharmacologically similar to the human neurokinin-3 receptor but is not of human origin

      MOLECULAR PHARMACOLOGY
    12. Wang, XK; Li, X; Schmidt, DB; Foley, JJ; Barone, FC; Ames, RS; Sarau, HM
      Identification and molecular characterization of rat CXCR3: Receptor expression and interferon-inducible protein-10 binding are increased in focal stroke

      MOLECULAR PHARMACOLOGY
    13. Sarau, HM; Griswold, DE; Bush, B; Potts, W; Sandhu, P; Lundberg, D; Foley, JJ; Schmidt, DB; Webb, EF; Martin, LD; Legos, JJ; Whitmore, RG; Barone, FC; Medhurst, AD; Luttmann, MA; Giardina, GAM; Hay, DWP
      Nonpeptide tachykinin receptor antagonists. II. Ppharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potentand selective NK-3 receptor antagonist

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    14. White, JR; Lee, JM; Dede, K; Imburgia, CS; Jurewicz, AJ; Chan, G; Fornwald, JA; Dhanak, D; Christmann, LT; Darcy, MG; Widdowson, KL; Foley, JJ; Schmidt, DB; Sarau, HM
      Identification of potent, selective non-peptide CC chemokine receptor-3 antagonist that inhibits eotaxin-, eotaxin-2-, and monocyte chemotactic protein-4-induced eosinophil migration

      JOURNAL OF BIOLOGICAL CHEMISTRY
    15. Elshourbagy, NA; Ames, RS; Fitzgerald, LR; Foley, JJ; Chambers, JK; Szekeres, PG; Evans, NA; Schmidt, DB; Buckley, PT; Dytko, GM; Murdock, PR; Milligan, G; Groarke, DA; Tan, KB; Shabon, U; Nuthulaganti, P; Wang, DY; Wilson, S; Bergsma, DJ; Sarau, HM
      Receptor for the pain modulatory neuropeptides FF and AF is an orphan G protein-coupled receptor

      JOURNAL OF BIOLOGICAL CHEMISTRY
    16. Chambers, JK; Macdonald, LE; Sarau, HM; Ames, RS; Freeman, K; Foley, JJ; Zhu, Y; McLaughlin, MM; Murdock, P; McMillan, L; Trill, J; Swift, A; Aiyar, N; Taylor, P; Vawter, L; Naheed, S; Szekeres, P; Hervieu, G; Scott, C; Watson, JM; Murphy, AJ; Duzic, E; Klein, C; Bergsma, DJ; Wilson, S; Livi, GP
      A G protein-coupled receptor for UDP-glucose

      JOURNAL OF BIOLOGICAL CHEMISTRY
    17. Douglas, SA; Sulpizio, AC; Piercy, V; Sarau, HM; Ames, RS; Aiyar, NV; Ohlstein, EH; Willette, RN
      Differential vasoconstrictor activity of human urotensin-II in vascular tissue isolated from the rat, mouse, dog, pig, marmoset and cynomolgus monkey

      BRITISH JOURNAL OF PHARMACOLOGY
    18. Fitzgerald, LR; Dytko, GM; Sarau, HM; Mannan, IJ; Ellis, C; Lane, PA; Tan, KB; Murdock, PR; Wilson, S; Bergsma, DJ; Ames, RS; Foley, JJ; Campbell, DA; McMillan, L; Evans, N; Elshourbagy, NA; Minehart, H; Tsui, P
      Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    19. Sarau, HM; Foley, JJ; Schmidt, DB; Martin, LD; Webb, EF; Tzimas, MN; Breton, JJ; Chabot-Fletcher, M; Underwood, DC; Hay, DWP; Kingsbury, WD; Chambers, PA; Pendrak, I; Jakas, DR; Sathe, GM; Van Horn, S; Daines, RA; Griswold, DE
      In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activity

      PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
    20. Wang, XK; Li, X; Yaish-Ohad, S; Sarau, HM; Barone, FC; Feuerstein, GZ
      Molecular cloning and expression of the rat monocyte chemotactic protein-3gene: a possible role in stroke

      MOLECULAR BRAIN RESEARCH
    21. Ames, RS; Sarau, HM; Chambers, JK; Willette, RN; Alyar, NV; Romanic, AM; Louden, CS; Foley, JJ; Sauermelch, CF; Coatney, RW; Ao, ZH; Disa, J; Holmes, SD; Stadel, JM; Martin, JD; Liu, WS; Glover, GI; Wilson, S; McNulty, DE; Ellis, CE; Elshourbagy, NA; Shabon, U; Trill, JJ; Hay, DWP; Ohlstein, EH; Bergsma, DJ; Douglas, SA
      Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14 (vol 401, pg 282, 1999)

      NATURE
    22. Ames, RS; Sarau, HM; Chambers, JK; Willette, RN; Alyar, NV; Romanic, AM; Louden, CS; Foley, JJ; Sauermelch, CF; Coatney, RW; Ao, ZH; Disa, J; Holmes, SD; Stadel, JM; Martin, JD; Liu, WS; Glover, GI; Wilson, S; McNulty, DE; Ellis, CE; Elshourbagy, NA; Shabon, U; Trill, JJ; Hay, DWP; Ohlstein, EH; Bergsma, DJ; Douglas, SA
      Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14

      NATURE
    23. Chambers, J; Ames, RS; Bergsma, D; Muir, A; Fitzgerald, LR; Hervieu, G; Dytko, GM; Foley, JJ; Martin, J; Liu, WS; Park, J; Ellis, C; Ganguly, S; Konchar, S; Cluderay, J; Leslie, R; Wilson, S; Sarau, HM
      Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1

      NATURE
    24. Sarau, HM; Ames, RS; Chambers, J; Ellis, C; Elshourbagy, N; Foley, JJ; Schmidt, DB; Muccitelli, RM; Jenkins, O; Murdock, PR; Herrity, NC; Halsey, W; Sathe, G; Muir, AI; Nuthulaganti, P; Dytko, GM; Buckley, PT; Wilson, S; Bergsma, DJ; Hay, DWP
      Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor

      MOLECULAR PHARMACOLOGY
    25. Giardina, GAM; Raveglia, LF; Grugni, M; Sarau, HM; Farina, C; Medhurst, AD; Graziani, D; Schmidt, DB; Rigolio, R; Luttmann, M; Cavagnera, S; Foley, JJ; Vecchietti, V; Hay, DWP
      Discovery of a novel class of selective non-peptide antagonists for the human neurokinin-3 receptor. 2. Identification of (S)-N-(1-phenylpropyl)-3-hydroxy-2-phenylquinoline-4-carboxamide (SB 223412)

      JOURNAL OF MEDICINAL CHEMISTRY
    26. Crass, T; Ames, RS; Sarau, HM; Tornetta, MA; Foley, JJ; Kohl, J; Klos, A; Bautsch, W
      Chimeric receptors of the human C3a receptor and C5a receptor (CD88)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    27. Giardina, GAM; Artico, M; Cavagnera, S; Cerri, A; Consolandi, E; Gagliardi, S; Graziani, D; Grugni, M; Hay, DWP; Luttmann, MA; Mena, R; Raveglia, LF; Rigolio, R; Sarau, HM; Schmidt, DB; Zanoni, G; Farina, C
      Replacement of the quinoline system in 2-phenyl-4-quinolinecarboxamide NK-3 receptor antagonists

      FARMACO
    28. Feild, JA; Foley, JJ; Testa, TT; Nuthulaganti, P; Ellis, C; Sarau, HM; Ames, RS
      Cloning and characterization of a rabbit ortholog of human G alpha 16 and mouse G alpha 15

      FEBS LETTERS
    29. VASTHARE US; BARONE FC; SARAU HM; ROSENWASSER RH; DIMARTINO M; YOUNG WF; TUMA RF
      COMPLEMENT DEPLETION IMPROVES NEUROLOGICAL FUNCTION IN CEREBRAL-ISCHEMIA

      Brain research bulletin
    30. AMES RS; TORNETTA MA; FOLEY JJ; SARAU HM; GANGULY S
      FUNCTIONAL, EXPRESSION OF THE HUMAN C3A RECEPTOR IN HEK-293 CELLS BY COEXPRESSION WITH G-ALPHA-16

      Molecular immunology
    31. CRASS T; AMES RS; TORNETTA MA; SARAU HM; FOLEY JJ; KOHL J; KLOS A; BAUTSCH W
      CHIMERIC RECEPTORS OF THE HUMAN C3A-RECEPTOR (C3AR) AND C5A-RECEPTOR (C5AR, CD88)

      Molecular immunology
    32. LIENENKLAUS S; AMES RS; TORNETTA MA; SARAU HM; FOLEY JJ; CRASS T; SOHNS B; RAFFETSEDER U; GROVE M; HOLZER A; KLOS A; KOHL J; BAUTSCH W
      HUMAN C4A ANAPHYLATOXIN ELICITS C3A-RECEPTOR MEDIATED EFFECTS IN GUINEA-PIGS BUT NOT IN MAN

      Molecular immunology
    33. LIENENKLAUS S; AMES RS; TORNETTA MA; SARAU HM; FOLEY JJ; CRASS T; SOHNS B; RAFFETSEDER U; GROVE M; HOLZER A; KLOS A; KOHL J; BAUTSCH W
      CUTTING EDGE - HUMAN ANAPHYLATOXIN C4A IS A POTENT AGONIST OF THE GUINEA-PIG BUT NOT THE HUMAN C3A RECEPTOR

      The Journal of immunology (1950)
    34. WHITE JR; LEE JM; YOUNG PR; HERTZBERG RP; JUREWICZ AJ; CHAIKIN MA; WIDDOWSON K; FOLEY JJ; MARTIN LD; GRISWOLD DE; SARAU HM
      IDENTIFICATION OF A POTENT, SELECTIVE NONPEPTIDE CXCR2 ANTAGONIST THAT INHIBITS INTERLEUKIN-8-INDUCED NEUTROPHIL MIGRATION

      The Journal of biological chemistry
    35. WHITE JR; IMBURGIA C; DUL E; APPELBAUM E; ODONNELL K; OSHANNESSY DJ; BRAWNER M; FORNWALD J; ADAMOU J; ELSHOURBAGY NA; KAISER K; FOLEY JJ; SCHMIDT DB; JOHANSON K; MACPHEE C; MOORES K; MCNULTY D; SCOTT GF; SCHLEIMER RP; SARAU HM
      CLONING AND FUNCTIONAL-CHARACTERIZATION OF A NOVEL HUMAN CC-CHEMOKINETHAT BINDS TO THE CCR3 RECEPTOR AND ACTIVATES HUMAN EOSINOPHILS

      Journal of leukocyte biology
    36. AMES RS; TORNETTA MA; FOLEY JJ; HUGLI TE; SARAU HM
      EVIDENCE THAT THE RECEPTOR FOR C4A IS DISTINCT FROM THE C3A RECEPTOR

      Immunopharmacology
    37. SARAU HM; RUSH JA; FOLEY JJ; BRAWNER ME; SCHMIDT DB; WHITE JR; BARNETTE MS
      CHARACTERIZATION OF FUNCTIONAL CHEMOKINE RECEPTORS (CCR1 AND CCR2) ONEOL-3 CELLS - A MODEL SYSTEM TO EXAMINE THE ROLE OF CHEMOKINES IN CELL-FUNCTION

      The Journal of pharmacology and experimental therapeutics
    38. SARAU HM; GRISWOLD DE; POTTS W; FOLEY JJ; SCHMIDT DB; WEBB EF; MARTIN LD; BRAWNER ME; ELSHOURBAGY NA; MEDHURST AD; GIARDINA GAM; HAY DWP
      NONPEPTIDE TACHYKININ RECEPTOR ANTAGONISTS .1. PHARMACOLOGICAL AND PHARMACOKINETIC CHARACTERIZATION OF SB-223412, A NOVEL, POTENT AND SELECTIVE NEUROKININ-3 RECEPTOR ANTAGONIST

      The Journal of pharmacology and experimental therapeutics
    39. GIARDINA GAM; SARAU HM; FARINA C; MEDHURST AD; GRUGNI M; RAVEGLIA LF; SCHMIDT DB; RIGOLIO R; LUTTMANN M; VECCHIETTI V; HAY DWP
      DISCOVERY OF A NOVEL CLASS OF SELECTIVE NONPEPTIDE ANTAGONISTS FOR THE HUMAN NEUROKININ-3 RECEPTOR .1. IDENTIFICATION OF THE 4-QUINOLINECARBOXAMIDE FRAMEWORK

      Journal of medicinal chemistry
    40. TORNETTA MA; FOLEY JJ; SARAU HM; AMES RS
      THE MOUSE ANAPHYLATOXIN C3A RECEPTOR - MOLECULAR-CLONING, GENOMIC ORGANIZATION, AND FUNCTIONAL EXPRESSION

      The Journal of immunology
    41. BERKHOUT TA; SARAU HM; MOORES K; WHITE JR; ELSHOURBAGY N; APPELBAUM E; REAPE TJ; BRAWNER M; MAKWANA J; FOLEY JJ; SCHMIDT DB; IMBURGIA C; MCNULTY D; MATTHEWS J; ODONNELL K; OSHANNESSY D; SCOTT M; GROOT PHE; MACPHEE C
      CLONING, IN-VITRO EXPRESSION, AND FUNCTIONAL-CHARACTERIZATION OF A NOVEL HUMAN CC CHEMOKINE OF THE MONOCYTE CHEMOTACTIC PROTEIN (MCP) FAMILY (MCP-4) THAT BINDS AND SIGNALS THROUGH THE CC CHEMOKINE RECEPTOR 2B

      The Journal of biological chemistry
    42. EISHOURBAGY NA; WHITE JR; BRAWNER ME; OSHANNESSY D; GROOT PH; RYNE P; TEMPLETON L; BERGSMA DJ; SARAU HM
      MOLECULAR CHARACTERIZATION OF A HUMAN CHEMOKINE RECEPTOR-LIKE THAT ISACTIVATED SELECTIVELY BY A UNIQUE CHEMOKINE CKB-4

      Circulation
    43. LOGAN TJ; NUTHULAGANTI P; WHITE JR; OHLSTEIN EH; SARAU HM; DEBOUCK C; BERGSMA DJ; EISHOURBAGY NA
      CHARACTERIZATION OF THE MONOCYTIC CHEMOKINE RECEPTOR HRBS11 - A POTENTIAL ROLE IN THE INFLAMMATORY RESPONSE TO VASCULAR INJURY

      Circulation
    44. DAINES RA; CHAMBERS PA; FOLEY JJ; GRISWOLD DE; KINGSBURY WD; MARTIN LD; SCHMIDT DB; SHAM KKC; SARAU HM
      ETHYL]-3-(2-PHENYLETHOXY)-2-PYRIDINYL]-2-PROPENOIC ACID - A HIGH-AFFINITY LEUKOTRIENE B-4 RECEPTOR ANTAGONIST WITH ORAL ANTIINFLAMMATORY ACTIVITY

      Journal of medicinal chemistry
    45. AMES RS; LI Y; SARAU HM; NUTHULAGANTI P; FOLEY JJ; ELLIS C; ZENG ZZ; SU K; JUREWICZ AJ; HERTZBERG RP; BERGSMA DJ; KUMAR C
      MOLECULAR-CLONING AND CHARACTERIZATION OF THE HUMAN ANAPHYLATOXIN C3ARECEPTOR

      The Journal of biological chemistry
    46. BARONE FC; HILLEGASS LM; TZIMAS MN; SCHMIDT DB; FOLEY JJ; WHITE RF; PRICE WJ; FEUERSTEIN GZ; CLARK RK; GRISWOLD DE; SARAU HM
      TIME-RELATED CHANGES IN MYELOPEROXIDASE ACTIVITY AND LEUKOTRIENE B-4 RECEPTOR-BINDING REFLECT LEUKOCYTE INFLUX IN CEREBRAL FOCAL STROKE

      Molecular and chemical neuropathology
    47. CHABOTFLETCHER MC; UNDERWOOD DC; BRETON JJ; ADAMS JL; KAGEYSOBOTKA A; GRISWOLD DE; MARSHALL LA; SARAU HM; WINKLER JD; HAY DWP
      PHARMACOLOGICAL CHARACTERIZATION OF SB-202235, A POTENT AND SELECTIVE5-LIPOXYGENASE INHIBITOR - EFFECTS IN MODELS OF ALLERGIC-ASTHMA

      The Journal of pharmacology and experimental therapeutics
    48. TORPHY TJ; ZHOU HL; FOLEY JJ; SARAU HM; MANNING CD; BARNETTE MS
      SALBUTAMOL UP-REGULATES PDE4 ACTIVITY AND INDUCES A HETEROLOGOUS DESENSITIZATION OF U937 CELLS TO PROSTAGLANDIN E(2) - IMPLICATIONS FOR THETHERAPEUTIC USE OF BETA-ADRENOCEPTOR AGONISTS

      The Journal of biological chemistry
    49. UNDIE AS; WEINSTOCK J; SARAU HM; FRIEDMAN E
      EVIDENCE FOR A DISTINCT D-1-LIKE DOPAMINE-RECEPTOR THAT COUPLES TO ACTIVATION OF PHOSPHOINOSITIDE METABOLISM IN BRAIN

      Journal of neurochemistry
    50. DAINES RA; CHAMBERS PA; EGGLESTON DS; FOLEY JJ; GRISWOLD DE; HALTIWANGER RC; JAKAS DR; KINGSBURY WD; MARTIN LD; PENDRAK I; SCHMIDT DB; TZIMAS MN; SARAU HM
      )OCTYL]OXY]-2-PYRIDINYL]METHYL]THIO]METHYL]BENZOIC ACID AND RELATED-COMPOUNDS - HIGH-AFFINITY LEUKOTRIENE B-4 RECEPTOR ANTAGONISTS

      Journal of medicinal chemistry
    51. BARNETTE MS; RUSH J; MARSHALL LA; FOLEY JJ; SCHMIDT DB; SARAU HM
      EFFECTS OF SCALARADIAL, A NOVEL INHIBITOR OF 14 KDA PHOSPHOLIPASE A(2), ON HUMAN NEUTROPHIL FUNCTION

      Biochemical pharmacology
    52. DAINES RA; CHAMBERS PA; PENDRAK I; JAKAS DR; SARAU HM; FOLEY JJ; SCHMIDT DB; GRISWOLD DE; MARTIN LD; TZIMAS MN; KINGSBURY WD
      CARBOXYETHENYL)-5-[[8-(4-METHOXYPHENYL)OCTY-1]OXY] -2-PYRIDINYL]METHYL]THIO]METHYL]BENZOIC ACID - A NOVEL HIGH-AFFINITY LEUKOTRIENE B-4 RECEPTOR ANTAGONIST (VOL 36, PG 2703, 1 993)

      Journal of medicinal chemistry
    53. KINGSBURY WD; PENDRAK I; LEBER JD; BOEHM JC; MALLET B; SARAU HM; FOLEY JJ; SCHMIDT DB; DAINES RA
      SYNTHESIS OF STRUCTURAL ANALOGS OF LEUKOTRIENE-B(4) AND THEIR RECEPTOR-BINDING ACTIVITY

      Journal of medicinal chemistry
    54. DAINES RA; CHAMBERS PA; PENDRAK I; JAKAS DR; SARAU HM; FOLEY JJ; SCHMIDT DB; KINGSBURY WD
      TRISUBSTITUTED PYRIDINE LEUKOTRIENE-B(4) RECEPTOR ANTAGONISTS - SYNTHESIS AND STRUCTURE-ACTIVITY-RELATIONSHIPS

      Journal of medicinal chemistry
    55. BOEHM JC; GLEASON JG; PENDRAK I; SARAU HM; SCHMIDT DB; FOLEY JJ; KINGSBURY WD
      SYNTHESIS AND LTB(4) RECEPTOR ANTAGONIST ACTIVITIES OF THE NATURALLY-OCCURRING LTB(4) RECEPTOR ANTAGONIST LEUCETTAMINE-A AND RELATED ANALOGS

      Journal of medicinal chemistry
    56. DAINES RA; CHAMBERS PA; PENDRAK I; JAKAS DR; SARAU HM; FOLEY JJ; SCHMIDT DB; GRISWOLD DE; MARTIN LD; KINGSBURY WD
      OCTYL]OXY]-2-PYRIDINYL]-METHYL]THIO]METHYL]BENZOIC ACID - A NOVEL HIGH-AFFINITY LEUKOTRIENE-B(4) RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    57. ZHOU HL; CHABOTFLETCHER M; FOLEY JJ; SARAU HM; TZIMAS MN; WINKLER JD; TORPHY TJ
      ASSOCIATION BETWEEN LEUKOTRIENE B4-INDUCED PHOSPHOLIPASE-D ACTIVATIONAND DEGRANULATION OF HUMAN NEUTROPHILS

      Biochemical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 08:06:25